The ROE (Return on Equity) of Hikma Pharmaceuticals PLC (HIK.L) is 15.54%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 15.54% |
| 2023-12-31 | 8.64% |
| 2022-12-31 | 8.81% |
| 2021-12-31 | 17.16% |
| 2020-12-31 | 20.19% |
| 2019-12-31 | 22.96% |
| 2018-12-31 | 16.74% |
| 2017-12-31 | -55.68% |
| 2016-12-31 | 6.47% |
| 2015-12-31 | 18.85% |